Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2012) | Total Docs. (3years) | Total Refs. (2012) | Total Cites (3years) | Citable Docs. (3years) |  Cites / Doc. (2years) |
Ref. / Doc. (2012) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Particle and Fibre Toxicology | journal | 3.221 Q1 | 119 | 49 | 106 | 2648 | 1166 | 102 | 11.00 | 54.04 |  |
| 2 | Nature Reviews Drug Discovery | journal | 6.540 Q1 | 391 | 219 | 663 | 7676 | 7103 | 437 | 10.67 | 35.05 | |
| 3 | Trends in Pharmacological Sciences | journal | 5.103 Q1 | 244 | 86 | 251 | 5885 | 2971 | 237 | 10.51 | 68.43 | |
| 4 | Natural Product Reports | journal | 3.623 Q1 | 211 | 72 | 242 | 10736 | 2497 | 233 | 9.99 | 149.11 | |
| 5 | Neuropsychopharmacology | journal | 4.716 Q1 | 249 | 282 | 758 | 18037 | 6223 | 723 | 8.26 | 63.96 | |
| 6 | Nanotoxicology | journal | 2.104 Q1 | 107 | 97 | 127 | 4515 | 994 | 123 | 7.40 | 46.55 | |
| 7 | Critical Reviews in Toxicology | journal | 2.025 Q1 | 129 | 42 | 117 | 5856 | 849 | 112 | 7.27 | 139.43 | |
| 8 | Clinical Pharmacokinetics | journal | 2.254 Q1 | 184 | 56 | 179 | 4291 | 1219 | 160 | 7.01 | 76.63 | |
| 9 | Drug Discovery Today | journal | 1.967 Q1 | 215 | 170 | 433 | 10127 | 2870 | 392 | 6.17 | 59.57 | |
| 10 | Expert Opinion on Drug Delivery | journal | 1.895 Q1 | 133 | 118 | 308 | 10235 | 1925 | 306 | 5.80 | 86.74 | |
| 11 | Pharmacogenomics Journal | journal | 1.599 Q1 | 95 | 63 | 144 | 2727 | 736 | 140 | 5.40 | 43.29 | |
| 12 | Journal of Antimicrobial Chemotherapy | journal | 2.283 Q1 | 221 | 529 | 1564 | 13759 | 7654 | 1219 | 5.04 | 26.01 | |
| 13 | Current Opinion in Drug Discovery and Development | journal | 1.905 Q1 | 85 | 0 | 141 | 0 | 755 | 135 | 5.01 | 0.00 | |
| 14 | International Journal of Neuropsychopharmacology | journal | 2.131 Q1 | 125 | 127 | 377 | 7517 | 1865 | 359 | 4.78 | 59.19 | |
| 15 | CNS Neuroscience and Therapeutics | journal | 1.604 Q1 | 91 | 164 | 170 | 6428 | 793 | 152 | 4.77 | 39.20 | |
| 16 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.515 Q1 | 99 | 23 | 76 | 1791 | 447 | 75 | 4.75 | 77.87 | |
| 17 | Toxicological Sciences | journal | 1.812 Q1 | 207 | 292 | 885 | 13467 | 4621 | 843 | 4.73 | 46.12 | |
| 18 | Journal of Nanobiotechnology | journal | 1.169 Q1 | 109 | 45 | 101 | 1810 | 470 | 101 | 4.69 | 40.22 | |
| 19 | Neuropharmacology | journal | 2.315 Q1 | 191 | 408 | 798 | 31474 | 4103 | 782 | 4.39 | 77.14 | |
| 20 | Expert Opinion on Therapeutic Targets | journal | 1.788 Q1 | 106 | 138 | 337 | 11271 | 1536 | 335 | 4.36 | 81.67 | |
| 21 | Expert Opinion on Investigational Drugs | journal | 1.486 Q1 | 117 | 161 | 456 | 12444 | 2063 | 446 | 4.32 | 77.29 | |
| 22 | Current Opinion in Investigational Drugs | journal | 1.470 Q1 | 83 | 0 | 280 | 0 | 1147 | 268 | 4.17 | 0.00 | |
| 23 | Expert Opinion on Biological Therapy | journal | 1.247 Q1 | 102 | 183 | 429 | 11683 | 1798 | 425 | 4.17 | 63.84 | |
| 24 | Environmental Pollution | journal | 2.038 Q1 | 301 | 429 | 1401 | 20283 | 6269 | 1383 | 4.12 | 47.28 | |
| 25 | Therapeutic Advances in Neurological Disorders | journal | 0.789 Q2 | 68 | 28 | 93 | 1970 | 302 | 89 | 4.05 | 70.36 | |
| 26 | Expert Review of Vaccines | journal | 1.331 Q1 | 105 | 150 | 465 | 8819 | 1801 | 378 | 3.92 | 58.79 | |
| 27 | Current Opinion in Molecular Therapeutics | journal | 1.262 Q1 | 67 | 0 | 165 | 0 | 650 | 159 | 3.91 | 0.00 | |
| 28 | Mutagenesis | journal | 1.353 Q1 | 102 | 88 | 242 | 4553 | 948 | 231 | 3.78 | 51.74 | |
| 29 | Journal of Psychopharmacology | journal | 1.443 Q1 | 135 | 176 | 525 | 11248 | 1996 | 489 | 3.75 | 63.91 | |
| 30 | Food and Chemical Toxicology | journal | 1.126 Q1 | 203 | 703 | 1482 | 28189 | 5984 | 1454 | 3.69 | 40.10 | |
| 31 | BioDrugs | journal | 1.106 Q1 | 79 | 42 | 130 | 3053 | 546 | 127 | 3.62 | 72.69 | |
| 32 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.942 Q2 | 100 | 127 | 366 | 10730 | 1396 | 363 | 3.62 | 84.49 | |
| 33 | British Journal of Clinical Pharmacology | journal | 1.372 Q1 | 167 | 242 | 658 | 8038 | 2445 | 517 | 3.54 | 33.21 | |
| 34 | Pharmacogenomics | journal | 0.968 Q2 | 100 | 207 | 538 | 8718 | 1872 | 450 | 3.51 | 42.12 | |
| 35 | Chinese Medicine | journal | 0.813 Q2 | 56 | 28 | 108 | 951 | 371 | 100 | 3.48 | 33.96 | |
| 36 | Expert Opinion on Therapeutic Patents | journal | 1.330 Q1 | 88 | 100 | 339 | 7922 | 1229 | 333 | 3.47 | 79.22 | |
| 37 | Drug Safety | journal | 1.778 Q1 | 140 | 111 | 298 | 4616 | 1179 | 235 | 3.43 | 41.59 | |
| 38 | Journal of Drug Targeting | journal | 1.025 Q1 | 107 | 82 | 265 | 5121 | 887 | 258 | 3.39 | 62.45 | |
| 39 | Antiviral Therapy | journal | 1.303 Q1 | 93 | 183 | 436 | 7095 | 1463 | 425 | 3.31 | 38.77 | |
| 40 | Toxicon | journal | 1.019 Q2 | 144 | 229 | 816 | 10969 | 2628 | 795 | 3.28 | 47.90 | |
| 41 | Bioorganic and Medicinal Chemistry | journal | 1.204 Q1 | 187 | 743 | 2565 | 28934 | 8864 | 2554 | 3.25 | 38.94 | |
| 42 | BMC Chemical Biology | journal | 0.860 Q2 | 21 | 5 | 16 | 189 | 47 | 16 | 3.22 | 37.80 | |
| 43 | Toxicology in Vitro | journal | 0.924 Q2 | 125 | 164 | 752 | 6781 | 2573 | 744 | 3.17 | 41.35 | |
| 44 | Journal of Exposure Science and Environmental Epidemiology | journal | 1.347 Q1 | 106 | 77 | 198 | 2860 | 623 | 189 | 3.16 | 37.14 | |
| 45 | Tetrahedron | journal | 1.329 Q1 | 236 | 1255 | 3673 | 64433 | 11679 | 3649 | 3.10 | 51.34 | |
| 46 | Expert Opinion on Emerging Drugs | journal | 0.898 Q2 | 54 | 44 | 137 | 4301 | 471 | 137 | 3.09 | 97.75 | |
| 47 | PharmacoEconomics | journal | 1.798 Q1 | 118 | 88 | 284 | 3813 | 992 | 237 | 3.09 | 43.33 | |
| 48 | BMC Pharmacology | journal | 0.623 Q2 | 48 | 8 | 49 | 343 | 134 | 49 | 3.07 | 42.88 | |
| 49 | ChemMedChem | journal | 1.142 Q1 | 119 | 215 | 664 | 10563 | 2075 | 642 | 3.00 | 49.13 | |
| 50 | Drug Testing and Analysis | journal | 0.806 Q1 | 67 | 150 | 278 | 4689 | 733 | 255 | 2.97 | 31.26 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data